HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

PR Newswire
October 26, 2019 — 19:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biotech Expansion genome healthcare pharmaceutical singapore technology University

Related News:

Lianlian Global Showcases Latest Innovations at Money 20/20 Asia 2024

April 25, 2024 — 23:52

INMOTION Debuts Innovational 2-in-1 Self-balancing Vehicle E20 at Global Sources HK Show 2024

April 25, 2024 — 23:50

Nature’s Miracle Announces Initial Shipments of the "MiracleTainer" Series Container Farm

April 25, 2024 — 23:30

Terra Drone, Unifly, and Aloft Technologies Launch UTM Development for AAM Targeting Global Markets

April 25, 2024 — 07:00

Jean-Michel Jarre is world’s first passenger to take off in KleinVision’s flying AirCar

April 24, 2024 — 13:00

Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever

April 24, 2024 — 13:00

Zepp Health Corporation Files 2023 Annual Report on Form 20-F

April 23, 2024 — 20:20

TTC Announces Strategic Expansion into Western Australia with New Perth Office

April 23, 2024 — 04:00

Tantech Holdings Ltd Announces $2.1 Million Private Placement

April 23, 2024 — 03:58